Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis

Núria Berenguer, Olivia Ferrández, Francesc Barbosa, Olatz Urbina, Merçè Espona, Santiago Grau

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

Resum

Anemia and/or thrombocytopenia are the most relevant adverse effects of linezolid treatment. We report the case of a patient under hemodialysis who developed osteomyelitis involving the amputation stump of the left limb due to a vancomycin-resistant and teicoplanin-resistant Enterococcus faecium successfully treated with linezolid for 6 months. Close monitorization of the patient probably contributed to maintenance of treatment with linezolid despite hematological alterations observed, which could be attributed to either the underlying patient's clinical condition or antimicrobial treatment. ©2012 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.
Idioma originalAnglès
Pàgines (de-a)226-228
RevistaJournal of Chemotherapy
Volum24
Número4
DOIs
Estat de la publicacióPublicada - 1 d’ag. 2012

Fingerprint

Navegar pels temes de recerca de 'Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis'. Junts formen un fingerprint únic.

Com citar-ho